JPS6058927A - 放射能標識血小板製剤 - Google Patents

放射能標識血小板製剤

Info

Publication number
JPS6058927A
JPS6058927A JP58167339A JP16733983A JPS6058927A JP S6058927 A JPS6058927 A JP S6058927A JP 58167339 A JP58167339 A JP 58167339A JP 16733983 A JP16733983 A JP 16733983A JP S6058927 A JPS6058927 A JP S6058927A
Authority
JP
Japan
Prior art keywords
labeled
iodine
metaraminol
preparation
platelet preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58167339A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0454651B2 (en, 2012
Inventor
Akira Yokoyama
横山　陽
Yoshiaki Omomo
大桃　善朗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON MEJIFUIJITSUKUSU KK
Nihon Medi Physics Co Ltd
Original Assignee
NIPPON MEJIFUIJITSUKUSU KK
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON MEJIFUIJITSUKUSU KK, Nihon Medi Physics Co Ltd filed Critical NIPPON MEJIFUIJITSUKUSU KK
Priority to JP58167339A priority Critical patent/JPS6058927A/ja
Priority to US06/564,653 priority patent/US4619823A/en
Priority to CA000444443A priority patent/CA1222451A/en
Priority to AU22998/83A priority patent/AU561695B2/en
Publication of JPS6058927A publication Critical patent/JPS6058927A/ja
Publication of JPH0454651B2 publication Critical patent/JPH0454651B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP58167339A 1983-09-09 1983-09-09 放射能標識血小板製剤 Granted JPS6058927A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP58167339A JPS6058927A (ja) 1983-09-09 1983-09-09 放射能標識血小板製剤
US06/564,653 US4619823A (en) 1983-09-09 1983-12-22 Radioactive iodine labeled metaraminol and diagnostic agent containing platelets labeled therewith
CA000444443A CA1222451A (en) 1983-09-09 1983-12-29 Radioactivity-labeled platelet preparation
AU22998/83A AU561695B2 (en) 1983-09-09 1983-12-30 Radioactive iodine labeled metaraminol for diagnostic purposes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58167339A JPS6058927A (ja) 1983-09-09 1983-09-09 放射能標識血小板製剤

Publications (2)

Publication Number Publication Date
JPS6058927A true JPS6058927A (ja) 1985-04-05
JPH0454651B2 JPH0454651B2 (en, 2012) 1992-08-31

Family

ID=15847896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58167339A Granted JPS6058927A (ja) 1983-09-09 1983-09-09 放射能標識血小板製剤

Country Status (4)

Country Link
US (1) US4619823A (en, 2012)
JP (1) JPS6058927A (en, 2012)
AU (1) AU561695B2 (en, 2012)
CA (1) CA1222451A (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005693A1 (en) * 1985-04-04 1986-10-09 Scripps Clinic And Research Corporation Detection of activated platelets with antibodies to cell surface antigens

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334369A (en) * 1991-06-11 1994-08-02 Medical University Of South Carolina Platelet receptor antagonists useful in detecting intravascular platelet aggregation
US7049140B1 (en) * 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US7306925B2 (en) * 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
KR101106533B1 (ko) * 2003-07-24 2012-01-20 브라코 이미징 에스.피.에이. 안정한 방사성의약 조성물 및 제조 방법
WO2006028993A2 (en) * 2004-09-02 2006-03-16 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
WO2016014939A1 (en) 2014-07-24 2016-01-28 Washington University Compositions targeting radiation-induced molecules and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1995709A (en) * 1931-09-22 1935-03-26 Sharp & Dohme Inc Hydroxyphenylpropanolamine hydrochloride
FR6087M (en, 2012) * 1967-01-10 1968-06-04
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
DE2427659C3 (de) * 1974-06-07 1979-08-16 Byk-Mallinckrodt, Chemische Produkte Gmbh, 6057 Dietzenbach Verfahren zur Herstellung von radioaktiv markierten Erythrozyten
US4298591A (en) * 1979-04-03 1981-11-03 The United States Of America As Represented By The United States Department Of Energy Instantaneous radioiodination of rose bengal at room temperature and a cold kit therefor
US4430319A (en) * 1982-05-21 1984-02-07 State University Of New York Radioactive iodine labeled phenolic amines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005693A1 (en) * 1985-04-04 1986-10-09 Scripps Clinic And Research Corporation Detection of activated platelets with antibodies to cell surface antigens
EP0216864B1 (en) * 1985-04-04 1992-05-20 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to cell surface antigens

Also Published As

Publication number Publication date
CA1222451A (en) 1987-06-02
JPH0454651B2 (en, 2012) 1992-08-31
US4619823A (en) 1986-10-28
AU561695B2 (en) 1987-05-14
AU2299883A (en) 1985-04-18

Similar Documents

Publication Publication Date Title
CA2109208C (en) Radiolabeled metal-binding protein for the treatment of arthritis
EP0273452B1 (en) High molecular compound comprising unit of asialoglycoprotein acceptor-directing compound and unit of chelate-forming compound chemically bonded thereto, and its utilisation
PL165699B1 (pl) Sposób wytwarzania srodka radiofarmaceutycznego PL PL
JPH036124B2 (en, 2012)
JPS5896031A (ja) 放射性診断剤およびその製造用組成物
JPS6058927A (ja) 放射能標識血小板製剤
KR860001565B1 (ko) 방사성 진단제의 제조방법
JPS6126887B2 (en, 2012)
US4564472A (en) 3-Aminomethylene-2,4-pentanedione bis(thiosemicarbazone) derivatives, and their production and use
US4042677A (en) Technetium-99m labeled radiodiagnostic agents and method of preparation
JPS641449B2 (en, 2012)
Chiotellis et al. Preparation of Tc-99m labeled pyridoxal-amino acid complexes and their evaluation
EP1004321B1 (en) Stable radioactive medecine
JP2564459B2 (ja) 放射性医薬品調製用キャリヤー
IE44077B1 (en) Technetium-99m-labelled diagnostic agent for kidney scanning and process for its manufacture
AU609569B2 (en) Tc-99m mononuclide complex compound
JPH0615478B2 (ja) 放射性医薬品とその調製用高分子化合物
JPH0416465B2 (en, 2012)
JP2677543B2 (ja) 生理活性物質結合高分子化合物および当該化合物を含む放射性医薬品調製用キャリアー
JPH0460974B2 (en, 2012)
JPS63170389A (ja) 放射性医薬品とその調製用高分子化合物
JPH0433767B2 (en, 2012)
JPS62275128A (ja) アミノ基と２官能性配位子を有する反応性高分子化合物とその利用
JPS62207282A (ja) テクネチウム−９９ｍ標識つき腎機能診断剤
JPH0414084B2 (en, 2012)